SILZONIQ Trademark

Trademark Overview

On Thursday, February 16, 2017, a trademark application was filed for SILZONIQ with the United States Patent and Trademark Office. The USPTO has given the SILZONIQ trademark a serial number of 87339192. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 15, 2019. This trademark is owned by XBIOTECH USA, INC.. The SILZONIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for use in chemotherapy and pharmaceutical preparations for the treatment of immune system related diseases and disorders
silzoniq

General Information

Serial Number87339192
Word MarkSILZONIQ
Filing DateThursday, February 16, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 15, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 17, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for use in chemotherapy and pharmaceutical preparations for the treatment of immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 23, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXBIOTECH USA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAustin, TX 78744
Party NameXBIOTECH USA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAustin, TX 78744

Trademark Events

Event DateEvent Description
Monday, April 15, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 15, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 11, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 17, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 17, 2018PUBLISHED FOR OPPOSITION
Wednesday, June 27, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 12, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, June 7, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 7, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, June 6, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 6, 2018EXAMINERS AMENDMENT E-MAILED
Wednesday, June 6, 2018EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 5, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 5, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, January 1, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, January 1, 2018FINAL REFUSAL E-MAILED
Monday, January 1, 2018FINAL REFUSAL WRITTEN
Thursday, December 7, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 7, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 29, 2017ASSIGNED TO LIE
Wednesday, November 15, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 18, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 18, 2017NON-FINAL ACTION E-MAILED
Thursday, May 18, 2017NON-FINAL ACTION WRITTEN
Thursday, May 11, 2017ASSIGNED TO EXAMINER
Thursday, February 23, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 20, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

silzoniq preparations pharmaceutical treatment diseases system disorders related immune infectious prevention